Clinical Trial Update: Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration [NA]

View source ↗

Summary

This clinical trial evaluates whether cyanobacteria affect the quantitative concentration of hepatitis B surface antigen (HBsAg) in adults who are chronic hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Cyanobacteria

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: HBV Carrier | NA | Status: UNKNOWN